Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer. Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, however, eventually these tumors acquire resistance to KI and patients succumb to their disease. Salvage therapy in t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://ncbi.nlm.nih.gov/pubmed/29996921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0378-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items